Is Cancer Immunotherapy More Hype Than Hope?
Abstract
The immunosurveillance system in the human body can detect and eradicate abnormal cells. However, cancer cells can avoid immune destruction by exploiting the immunosuppression system. Extensive research has been done to find therapeutic agents that could reverse this condition. Novel drugs called checkpoint inhibitors have been developed and showed a promising result. Besides, “living’’ drug, an engineered T-cells which can accurately target cancer cells, has increased public attention in immunotherapy. These immunotherapies might bring a new era of cancer management, a highly effective and specific treatment with fewer adverse effects. Keywords: Immunosurveillance; T-Cell; Therapeutic agents; ImmunotherapiesDownloads
Download data is not yet available.
Published
2020-08-31
How to Cite
1.
Lesmana R, Hadi E, Goenawan H. Is Cancer Immunotherapy More Hype Than Hope?. JMH [Internet]. 31Aug.2020 [cited 16Jan.2021];2(6). Available from: https://journal.maranatha.edu/index.php/jmh/article/view/2826
Issue
Section
Articles
Copyright (c) 2020 Journal of Medicine and Health

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.